FDA Drug/Biologics Approval BLA 125387 S-020, AFLIBERCEPT

FDA Drug/Biologics Approval BLA 125387 S-020, AFLIBERCEPT

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125387 S-020
Company: REGENERON PHARMACEUTICALS
Drug Name: EYLEA
Active Ingredients: AFLIBERCEPT
Strength: 40MG/ML
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 11/18/2011
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details